http://www.prnewswire.com/news-releases/biolife-solutions-adds-clinical-and-commercialization-experts-to-scientific-advisory-board-137876168.html
BOTHELL, Wash., Jan. 23, 2012 /PRNewswire/ -- Bio Life Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells, tissues, and organs, today announced that three additional key opinion leaders in the biobanking, drug discovery, and regenerative medicine markets have joined the Company's Scientific Advisory Board (SAB). The new members are:
John McMannis, Ph.D., Executive Vice President of Manufacturing at Mesoblast Limited. Dr. McMannis was previously the Director, Cellular Therapy Laboratory, Department of Stem Cell Transplantation, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
http://www.prnewswire.com/news-releases/biolife-solutions-adds-cl...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |